Dosage-related effects of danazol on sex hormone binding globulin and free and total androgen levels. 1986

K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate

Danazol is known to cause marked suppression of sex hormone binding globulin (SHBG) levels in plasma and to increase the proportion of plasma testosterone unbound to protein but the effect on the concentration of total and free testosterone is unclear. Twenty-five patients with endometriosis were treated daily for 6 months with doses of danazol ranging from 50 to 600 mg. The fall in SHBG and rise in percent free testosterone was dose-related during the early part of treatment. Suppression of total testosterone and 5 alpha-dihydrotestosterone levels occurred and was probably due to increases in metabolic clearance rates. The observed fall in androstenedione levels was related to the incidence of menstrual abnormality, suggesting that this might be due to reduced ovarian activity. The concentration of free testosterone increased by a factor of two in the first week but subsequently returned to levels of between 25 and 50% above pretreatment levels. This pattern of changes may be due to the rise in metabolic clearance rates being dependent on induction of enzymes of androgen metabolism.

UI MeSH Term Description Entries
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012738 Sex Hormone-Binding Globulin A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications. Sex Steroid-Binding Protein,Testosterone-Estradiol Binding Globulin,Binding Globulin, Testosterone-Estradiol,Globulin, Sex Hormone-Binding,Globulin, Testosterone-Estradiol Binding,Hormone-Binding Globulin, Sex,Sex Hormone Binding Globulin,Sex Steroid Binding Protein,Steroid-Binding Protein, Sex,Testosterone Estradiol Binding Globulin

Related Publications

K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
June 1985, Nihon Sanka Fujinka Gakkai zasshi,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
April 1990, Contraception,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
December 2016, Molecular and cellular endocrinology,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
March 1999, Calcified tissue international,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
March 1983, The Journal of clinical endocrinology and metabolism,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
July 2015, Steroids,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
September 1983, The Journal of clinical endocrinology and metabolism,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
July 1982, Fertility and sterility,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
January 1996, European journal of applied physiology and occupational physiology,
K L Forbes, and M Dowsett, and G L Rose, and J E Mudge, and S L Jeffcoate
November 1983, Acta endocrinologica,
Copied contents to your clipboard!